Could group MDMA therapy heal trauma from oct 7?

NCT ID NCT07469098

Recruiting now Symptom relief Sponsor: Sheba Medical Center Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether group-based MDMA-assisted therapy works as well as individual sessions for people with PTSD linked to the October 7, 2023 events. 168 participants will receive MDMA in either a group or individual setting, along with therapy sessions. The goal is to see if group therapy is a safe and effective option to help more people access treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: MDMA (also known as ecstasy or molly)
What this could lead to: If successful, this could show that group therapy with MDMA is as safe and effective as individual sessions, making treatment more accessible for people with PTSD.
What could go wrong: This is an early Phase 2 trial with only 168 participants, so results may not apply to everyone. MDMA can cause side effects like anxiety, nausea, and increased heart rate, and the therapy is still experimental.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PTSD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

post-traumatic stress disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PTSD

Contacts and locations

Locations

Lev-Hasharon Mental Health Medical Center
RECRUITING

Pardesiyya, Israel
Mental Health Medical Center Beer Sheva
RECRUITING

Beersheba, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.